Comparison of 225actinium chelates: tissue distribution and radiotoxicity
- PMID: 10473198
- DOI: 10.1016/s0969-8051(99)00024-4
Comparison of 225actinium chelates: tissue distribution and radiotoxicity
Abstract
The biodistribution and tissue toxicity of intravenously administered 225-actinium (225Ac) complexed with acetate, ethylene diamine tetraacetic acid (EDTA), 1, 4, 7, 10, 13-pentaazacyclopentadecane-N, N', N", N"', N""-pentaacetic acid (PEPA), or the "a" isomer of cyclohexyl diethylenetriamine pentaacetic acid (CHX-DTPA), were examined. The percent of injected dose per organ and per gram of tissue for each chelate complex was determined. 225Ac-CHX-DTPA was evaluated further for radiotoxic effects. Mice receiving > or =185 kBq 225Ac-CHX-DTPA suffered 100% morbidity by 5 days and 100% mortality by 8 days postinjection, and all animals evaluated had significant organ damage. The in vivo instability of the 225Ac-CHX-DTPA complex likely allowed accumulation of free 225Ac in organs, which resulted in tissue pathology.
Similar articles
-
Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies.J Nucl Med. 1998 May;39(5):829-36. J Nucl Med. 1998. PMID: 9591585
-
Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.Nucl Med Biol. 2011 Nov;38(8):1119-27. doi: 10.1016/j.nucmedbio.2011.05.003. Epub 2011 Jul 7. Nucl Med Biol. 2011. PMID: 21741258 Free PMC article.
-
In vivo Evaluation of Free and Chelated Accelerator-produced Actinium- 225 - Radiation Dosimetry and Toxicity Results.Curr Radiopharm. 2018;11(3):215-222. doi: 10.2174/1874471011666180423120707. Curr Radiopharm. 2018. PMID: 29683101
-
Should DTPA, an Aminocarboxylic acid (ethylenediamine-based) chelating agent, be considered a developmental toxicant?Regul Toxicol Pharmacol. 2018 Aug;97:197-208. doi: 10.1016/j.yrtph.2018.06.019. Epub 2018 Jun 28. Regul Toxicol Pharmacol. 2018. PMID: 29964121 Review.
-
Zinc deficiency induced by the chelating agent DTPA and its regulatory interpretation for developmental toxicity classification.Regul Toxicol Pharmacol. 2024 Feb;147:105540. doi: 10.1016/j.yrtph.2023.105540. Epub 2023 Dec 8. Regul Toxicol Pharmacol. 2024. PMID: 38070761 Review.
Cited by
-
Development of 225Ac-doped biocompatible nanoparticles for targeted alpha therapy.J Nanobiotechnology. 2024 Jun 2;22(1):306. doi: 10.1186/s12951-024-02520-6. J Nanobiotechnology. 2024. PMID: 38825717 Free PMC article.
-
Actinium-225 targeted alpha particle therapy for prostate cancer.Theranostics. 2024 May 11;14(7):2969-2992. doi: 10.7150/thno.96403. eCollection 2024. Theranostics. 2024. PMID: 38773983 Free PMC article. Review.
-
Alpha-Emitting Radionuclides: Current Status and Future Perspectives.Pharmaceuticals (Basel). 2024 Jan 8;17(1):76. doi: 10.3390/ph17010076. Pharmaceuticals (Basel). 2024. PMID: 38256909 Free PMC article. Review.
-
[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts.EJNMMI Radiopharm Chem. 2023 Sep 26;8(1):24. doi: 10.1186/s41181-023-00208-0. EJNMMI Radiopharm Chem. 2023. PMID: 37750937 Free PMC article.
-
Targeted Alpha-Particle Therapy: A Review of Current Trials.Int J Mol Sci. 2023 Jul 19;24(14):11626. doi: 10.3390/ijms241411626. Int J Mol Sci. 2023. PMID: 37511386 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous